Stock Research for NVAX

NVAX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NVAX Stock Chart & Research Data

The NVAX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NVAX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NVAX Due diligence Resources & Stock Charts

The NVAX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NVAX Detailed Price Forecast - CNN Money CNN View NVAX Detailed Summary - Google Finance
Yahoo View NVAX Detailed Summary - Yahoo! Finance Zacks View NVAX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View NVAX Trends & Analysis - Trade-Ideas Barrons View NVAX Major Holders - Barrons
NASDAQ View NVAX Call Transcripts - NASDAQ Seeking View NVAX Breaking News & Analysis - Seeking Alpha
Spotlight View NVAX Annual Report - CompanySpotlight.com OTC Report View NVAX OTC Short Report - OTCShortReport.com
TradeKing View NVAX Fundamentals - TradeKing Charts View NVAX SEC Filings - Bar Chart
WSJ View Historical Prices for NVAX - The WSJ Morningstar View Performance/Total Return for NVAX - Morningstar
MarketWatch View the Analyst Estimates for NVAX - MarketWatch CNBC View the Earnings History for NVAX - CNBC
StockMarketWatch View the NVAX Earnings - StockMarketWatch MacroAxis View NVAX Buy or Sell Recommendations - MacroAxis
Bullish View the NVAX Bullish Patterns - American Bulls Short Pains View NVAX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View NVAX Stock Mentions - StockTwits PennyStocks View NVAX Stock Mentions - PennyStockTweets
Twitter View NVAX Stock Mentions - Twitter Invest Hub View NVAX Investment Forum News - Investor Hub
Yahoo View NVAX Stock Mentions - Yahoo! Message Board Seeking Alpha View NVAX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for NVAX - SECform4.com Insider Cow View Insider Transactions for NVAX - Insider Cow
CNBC View NVAX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NVAX - OTC Markets
Yahoo View Insider Transactions for NVAX - Yahoo! Finance NASDAQ View Institutional Holdings for NVAX - NASDAQ


Stock Charts

FinViz View NVAX Stock Insight & Charts - FinViz.com StockCharts View NVAX Investment Charts - StockCharts.com
BarChart View NVAX Stock Overview & Charts - BarChart Trading View View NVAX User Generated Charts - Trading View




Latest Financial News for NVAX


Novavax Shares Gain as its Lead Compounds Move Forward, Analysts Review and Target
Posted on Monday October 15, 2018

NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Novavax, Inc. (NVAX), a biotechnology company focused on the discovery and development of innovative vaccines to prevent serious respiratory diseases. The company's products are targeted for worldwide markets and its core commercial team is already laying the groundwork before launching with government policymakers, provider, payers, associations, advocates and opinion leaders in advance of regulatory approval.


3 Top Small-Cap Stocks to Buy in October
Posted on Sunday October 14, 2018

Big rewards can be found in small packages.


Top 3 Healthcare Penny Stocks for 2018
Posted on Wednesday October 10, 2018

The healthcare industry can be precarious for stocks of large companies, much less penny stocks. None of these are new companies – they have made progress in developing products and finding the marketing outlets that are needed to sustain them. Because of the higher risk, investors should continuously perform due diligence.


Here's Why Novavax Gained 20.5% in September
Posted on Wednesday October 10, 2018

A Wall Street analyst turned bullish -- and the market responded in kind. But investors may want to consider the binary nature of this biopharma stock.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.